Tolazoline-augmented arteriography in the evaluation of bone and soft-tissue tumors.
Twelve patients with bone tumors were prospectively evaluated by arteriography both with and without tolazoline. In general, tolazoline improved definition of tumor extent; however, in 2 patients with highly vascular tumors and 2 patients with hypovascular tumors, tolazoline did not improve visualization. In 3 of the 12 patients, the tolazoline-augmented study was less accurate than the nontolazoline study in defining tumor extent.
D000293:Adolescent; D000328:Adult; D000792:Angiography / Q000379:methods*; D001859:Bone Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007089:Image Enhancement; D008297:Male; D012983:Soft Tissue Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging*; D014043:Tolazoline / Q000008:administration & dosage*
D014043:Tolazoline